---
title: "CF, NUE lead top 10 large-cap U.S. materials stocks with strong momentum grades"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/299341047.md"
description: "CF Industries and Nucor lead a list of top-performing large-cap U.S. materials stocks with strong price momentum grades. CF holds an A+ grade with a 70.66% year-to-date return, while NUE also has an A+ grade with a 59.82% return. Other notable performers include Freeport-McMoRan, Newmont, and Southern Copper, all achieving A-grade momentum. This ranking highlights superior price performance trends within the chemicals, metals, packaging, and mining sectors compared to industry peers."
datetime: "2026-09-17T15:15:12.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/299341047.md)
  - [en](https://longbridge.com/en/news/299341047.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/299341047.md)
generator: "portal-rs"
---

# CF, NUE lead top 10 large-cap U.S. materials stocks with strong momentum grades


### Related Stocks

- [FCX.US](https://longbridge.com/en/quote/FCX.US.md)
- [CF.US](https://longbridge.com/en/quote/CF.US.md)
- [SCCO.US](https://longbridge.com/en/quote/SCCO.US.md)
- [NEM.US](https://longbridge.com/en/quote/NEM.US.md)
- [NUE.US](https://longbridge.com/en/quote/NUE.US.md)
- [NWMX.US](https://longbridge.com/en/quote/NWMX.US.md)

## Related News & Research

- [Nucor (NYSE:NUE) Issues Q3 2026 Earnings Guidance](https://longbridge.com/en/news/299370161.md)
- [Nucor Guides to Higher Q3 Profit, but Below Analysts' Estimate](https://longbridge.com/en/news/299493282.md)
- [Nucor (NUE) Is Back In The Spotlight, What Is Drawing Attention?](https://longbridge.com/en/news/298802308.md)
- [Corient Private Wealth LP Buys 17,405 Shares of Freeport-McMoRan Inc. $FCX](https://longbridge.com/en/news/299014620.md)
- [Freeport-McMoRan Eyes Leach Breakthrough, Bagdad Growth and Grasberg Recovery](https://longbridge.com/en/news/299234764.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**